Sustainability Key To ABL Bio’s Journey From ‘Good To Great’

Goal To Become An R&D-Focused Subsidiary

 
• By Jung Won Shin
  
Sang Hoon Lee, CEO of ABL Bio
Sanofi, GSK Deals Part Of Korean Venture's Goal Of Building Financial Sustainability (ABL Bio)

More from South Korea

More from Anticancer